Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:PG 28:0)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST004167 AN006917 Targeted Lipidomic Profiling of STBD1 Knockdown in Clear Cell Renal Carcinoma Cells Renal cancer cells Human Cancer The Affiliated Cancer Hospital of Zhengzhou University LC-MS
ST003401 AN005582 The double-edged role of FASII regulator FabT in Streptococcus pyogenes infection - Lipidomics Bacterial cells Streptococcus pyogenes Bacterial infection INSERM APCI-MS
ST003053 AN005007 Providing insight into the mechanism of action of Cationic Lipidated Oligomers (CLOs) using metabolomics Bacterial cells Staphylococcus aureus Bacterial infection Monash University LC-MS
ST002411 AN003930 Spatial, temporal, and inter-subject variation of the metabolome along the human upper intestinal tract (MS RP negative data) Intestine Human University of California, Davis LC-MS
ST001304 AN002173 Multi-omics analysis delineates the distinct functions of sub-cellular acetyl-CoA pools in Toxoplasma gondii Fibroblast cells Toxoplasma gondii Parasitic infection Monash University LC-MS
ST001269 AN002109 Exosomal lipids for classifying early and late stage non-small cell lung cancer Blood Human Cancer University of Kentucky MS(Dir. Inf.)
ST000076 AN000121 A549 Cell Study Lung Human University of Kentucky GC-MS/LC-MS
  logo